Lv3
340 积分 2023-01-09 加入
Atherosclerosis in diabetes mellitus: novel mechanisms and mechanism-based therapeutic approaches
16小时前
已完结
RNA Interference With Zilebesiran for Mild to Moderate Hypertension
13天前
已完结
Prevalence of Elevated Lipoprotein(a) and its Association With Subclinical Atherosclerosis in 2.9 Million Chinese Adults
17天前
已完结
Zodasiran, an RNAi Therapeutic Targeting ANGPTL3, for Mixed Hyperlipidemia
1个月前
已完结
Regulatory role and translational potential of CCL11 in liver fibrosis
1个月前
已完结
Targeting APOC3 with Olezarsen in Moderate Hypertriglyceridemia
1个月前
已关闭
Adjuvant Pembrolizumab versus Observation in Muscle-Invasive Urothelial Carcinoma
1个月前
已完结
Olezarsen for Hypertriglyceridemia in Patients at High Cardiovascular Risk
1个月前
已完结
Olezarsen for Hypertriglyceridemia in Patients at High Cardiovascular Risk
1个月前
已完结
PCSK9 Inhibition with alirocumab increases the catabolism of lipoprotein(a) particles in statin-treated patients with elevated lipoprotein(a)
1个月前
已完结
皖公网安备34019202002308
